Position in BLLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$41,307,552
+$31,708,133 QoQ
Shares Held
344,287
+183.1% QoQ
Ownership
0.730%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#14
of 156 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026UBS Group AG holds $4,492,966,338 across 42 Diagnostics & Research names. BLLN ranks #18 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,521,208 | $1,264,032,836 | |
| 2 | DHR |
Danaher Corp /De/
|
3,243,524 | $617,826,447 | |
| 3 | WAT |
Waters Corp /De/
|
694,851 | $260,596,916 | |
| 4 | A |
Agilent Technologies, Inc.
|
1,574,629 | $209,157,967 | |
| 5 | RVTY |
Revvity, Inc.
|
1,864,464 | $207,440,262 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
364,663 | $191,973,186 | |
| 7 | DGX |
Quest Diagnostics Inc
|
888,906 | $188,403,625 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
128,025 | $163,553,216 |
All Filings in BLLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,307,552 | 344,287 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $9,599,419 | 121,604 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,586,061 | 31,599 | Shares | Defined | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||